B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

FGFR1

MOLECULAR TARGET

fibroblast growth factor receptor 1

NCBI Gene: 226072 compounds

FGFR1 (fibroblast growth factor receptor 1) is targeted by 72 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting FGFR1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1cabozantinib4.3980
2foretinib4.3476
3tozasertib4.3375
4vandetanib4.3073
5ponatinib4.2670
6doramapimod4.0657
7semaxanib3.9350
8midostaurin3.8546
9brigatinib3.8144
10pazopanib3.6939
11nintedanib3.6136
12regorafenib3.5634
13tae 6843.4330
14fedratinib3.4029
15linifanib3.3327
16mln 80543.3327
17fexagratinib3.3327
18dovitinib3.0921
19jnj 77066213.0921
20at 92833.0921
21upadacitinib3.0921
22lestaurtinib3.0420
23lenvatinib3.0420
24pf 037583093.0019
25ruboxistaurin2.9418
26danusertib2.9418
27orantinib2.8917
28r 4062.8316
29cediranib2.8316
30pd 01662852.8316
31pd 1730742.8316
32milciclib2.7715
33infigratinib2.7715
34capivasertib2.7715
35erdafitinib2.7715
36pha 6657522.7114
37plx 47202.7114
38enmd 20762.7114
39kw 24492.6413
40tivozanib2.6413
41Sorafenib2.5612
42ast 4872.5612
43ly 28744552.5612
44raf 2652.4811
45motesanib2.4811
46brivanib2.4811
47pemigatinib2.4010
48bms 7548072.309
49azd 14802.309
50su 0148132.208

Showing top 50 of 72 compounds. Use the BiohacksAI search to explore all FGFR1 modulators.

About FGFR1 as a Drug Target

FGFR1 (fibroblast growth factor receptor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 72 compounds with documented FGFR1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

FGFR1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.